Promising drug for painful hair loss condition enters pilot trial
NCT ID NCT07396168
First seen Feb 10, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tests a drug called nemolizumab for lichen planopilaris (LPP), a rare condition that causes permanent hair loss and scalp itching or burning. Ten adults with LPP will receive the drug for 24 weeks to see if it reduces disease activity and symptoms. The goal is to find a better treatment option for people who don't respond well to current therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN PLANO-PILARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Skin Center Dermatology Group
RECRUITINGNew City, New York, 10956, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.